• Quantum computing in pharma Sarah Harding
    December 17, 2021
    The topic of quantum computing just keeps on cropping up. There doesn’t seem to be any sector that isn’t enthralled by the potential that the quantum revolution will bring – and pharma is no different.
  • Has COVID been injecting cash into pharma? Sarah Harding
    December 17, 2021
    The impact of COVID on our lives and economies can, in many sectors, only be described as seismic. Casualties include the commercial property market, the hospitality and entertainment industries...
  • Changing landscape of pharma market in Central Asia & Russia Dr. Preet Pal S.B.
    September 26, 2021
    Russia and parts of Central Asia have made the most significant regulatory changes in their history in 2021. They have almost completed the steps needed to form a unified market like the EU.
  • A Smarter Pharma Industry: The Key to Addressing Challenges During the COVID-19 Pandemic Sarah Harding
    December 24, 2020
    China has been viewed in recent years as a ‘rising star’ of the pharma industry. Notwithstanding political pressures – primarily from the US – founded on concerns over China’s growing dominance in the field.
  • Evolving World of Pharma: A framework for funding innovation Sarah Harding
    April 09, 2020
    Modern R&D models are being built on the integration of physical, chemical and computer sciences, and a commercial model that is increasingly played out within a framework of external funding for innovation. Under this model, new biotechs and other start-
  • Pharma Budget 2022 ExpressPharma
    January 19, 2022
    Pharma leaders and experts share their concerns about the industry, and expectations from Budget 2022.
  • CPhI Worldwide releases pharma market predictions for 2022 ExpressPharma
    January 05, 2022
    CPhI Worldwide has released its beginning of year pharma market predictions for 2022 combining research from more than 350 pharma executives and expert views from 10 CPhI contributors, as per a statement from CPhI.
  • Third Former GlaxoSmithKline Scientist Pleads Guilty to Stealing Trade Secrets to Benefit Chinese Pharma Company FirstWordPharma
    January 04, 2022
    United States Attorney Jennifer Arbittier Williams announced that Lucy Xi, 44, formerly a resident of Malvern, PA, pleaded guilty to conspiracy to steal trade secrets from GlaxoSmithKline (GSK) to benefit a Chinese pharmaceutical company named Renopharma.
  • New Digital Grand Challenge announced by CPI EuropeanPharmaceuticalReview
    December 22, 2021
    The Centre for Process Innovation (CPI) reveals the National Physical Laboratory, StreamNative and Wyoming will collaborate on new projects to drive digital medicines manufacturing technology.
  • CPhI releases Pharma Trends 2022 report CPhIonline
    December 09, 2021
    CPhI has launched its forward-looking pharma trend report for 2022 and it is now available to read on CPhI Online.
PharmaSources Customer Service